Search
for
Sort by
Research 121–150 of 1000+
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Dermatological adverse events with taxane chemotherapy
- AGD1, a class 1 ARF‐GAP, acts in common signaling pathways with phosphoinositide metabolism and the actin cytoskeleton in controlling Arabidopsis root hair polarity
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Vitamin D metabolism and function in the skin
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- Hidradenitis suppurativa and major adverse cardiac events: A systematic review and meta-analysis
- Cardiovascular and Metabolic Risk Profiles Across Different Phenotypes of Polycystic Ovary Syndrome
- Cutaneous manifestations of metabolic diseases: uncommon presentations
- Follow-up of Nutritional and Metabolic Problems After Bariatric Surgery
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Lipid Profile and Metabolic Syndrome Status in Patients with Oral Lichen Planus, Oral Lichenoid Reaction and Healthy Individuals Attending a Dental College in Northern India - A Descriptive Study
- Hair and nail adverse events during treatment with target therapies for metastatic melanoma
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- Reporting on Adverse Clinical Events
- Reporting on Adverse Clinical Events
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Relationship Between Steroid Hormones and Metabolic Profile in Women With Polycystic Ovary Syndrome
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- “Nail loss after teriflunomide treatment: A new potential adverse event”
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Lichen planus and dyslipidemia: a systematic review and meta-analysis of observational studies
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients
- Epigenetic orchestration of RNA m<sup>6</sup>A methylation in wound healing and post-wound events